MOLECULAR DOCKING STUDY OF EPIGALLOCATECHIN GALLATE (EGCG) AS A THERAPY FOR TYPE 2 DIABETES MELLITUS
Epigallocatechin gallate (EGCG) has an effect in reducing sugar levels in the blood by inhibiting α-glucosidase enzyme, which is connected explicitly by hydrogen bonds and modifies the secondary structure and micro-environment of the enzyme reversibly and non-competitive. This study looks at the act...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2024-06-01
|
Series: | Jurnal Kimia Riset |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JKR/article/view/56399 |